Skip to main content

Table 1 Trial registration data from the World Health Organization Trial Registration Data Set

From: Tailored multifactorial intervention to improve dizziness symptoms and quality of life, balance and gait in dizziness sufferers aged over 50 years: protocol for a randomised controlled trial

Data category

Information

Primary registry and trial identifying number

anzctr.org.au

ACTRN12612000379819

Date of registration in primary registry

3 April 2012

Secondary identifying numbers

N/A

Source(s) of monetary or material support

Australian National Health and Medical Research Council

Primary sponsor

Professor Stephen Lord, Neuroscience Research Australia

Secondary sponsor

Dr Jasmine Menant, Neuroscience Research Australia

Contact for public queries

Professor Stephen Lord, DSc [S.Lord@neura.edu.au]

Contact for scientific queries

Professor Stephen Lord, DSc

Neuroscience Research Australia, Randwick Sydney, Australia

Public title

Treating dizziness in older people

Scientific title

A randomised controlled trial of dizziness interventions based on a multidisciplinary assessment in older people: towards the development of a multiple profile assessment of dizziness – the MPA-D

Countries of recruitment

Australia

Health condition(s) or problem(s) studied

Dizziness in older people

Intervention(s)

Active comparator: Multifaceted tailored intervention including a home exercise program, a vestibular rehabilitation program, a booklet-based cognitive behavioural therapy, and/or a comprehensive geriatric assessment and medication review.

Placebo comparator: usual care, no intervention

Key inclusion and exclusion criteria

Ages eligible for study: ≥50 years

Sexes eligible for study: both

Accepts healthy volunteers: yes

Inclusion criteria: adult patient (≥50 years), having experienced one or more episode(s) of dizziness in the past year and not being currently treated for it; living independently in the community or retirement village; able to understand English.

Exclusion criteria: presence of a diagnosed degenerative neurological condition or severe cognitive impairment (GP-Cog score equal or below 4).

Study type

Interventional

Allocation: randomized intervention model. Parallel assignment masking: single blind (investigator, outcomes assessor)

Primary purpose: prevention

Phase III

Date of first enrolment

August 2012

Target sample size

300

Recruitment status

Completed

Primary outcome(s)

• Frequency and duration of dizziness episodes experienced in the 6-months period between baseline and re-test.

• Dizziness-related quality of life recorded using a validated questionnaire, the Dizziness Handicap Inventory

• Choice stepping reaction time: a composite measure of reaction time, strength and balance.

Time points for all outcomes: baseline and 6 months post-baseline (i-e at the end of the intervention period)

Key secondary outcomes

• Tilt table test of orthostatic hypotension

• Coordinated Stability - a test of leaning balance

• Geriatric depression scale - 15 items: a questionnaire to assess depression disorders

Time points for all outcomes: baseline and 6 months post-baseline (i-e at the end of the intervention period)